Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of atezolizumab, bevacizumab, carboplatin, and paclitaxel that can be used in the treatment of cervical cancer and non-small cell lung cancer (NSCLC).

**Synonyms:** - ABCP - ABCP - ABCP (bevacizumab-adcd) - ABCP (bevacizumab-awwb) - ABCP (bevacizumab-aybi) - ABCP (bevacizumab-bvzr) - ABCP (bevacizumab-equi) - ABCP (bevacizumab-maly) - ABCP (bevacizumab-onbe) - ABCP (bevacizumab-tnjn) - ABCP Regimen - Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel - Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel Regimen - Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel - Carboplatin and Paclitaxel (CP), Atezolizumab, Bevacizumab - Carboplatin and Paclitaxel (CP), Atezolizumab, Bevacizumab-adcd - Carboplatin and Paclitaxel (CP), Atezolizumab, Bevacizumab-awwb - Carboplatin and Paclitaxel (CP), Atezolizumab, Bevacizumab-aybi - Carboplatin and Paclitaxel (CP), Atezolizumab, Bevacizumab-bvzr - Carboplatin and Paclitaxel (CP), Atezolizumab, Bevacizumab-equi - Carboplatin and Paclitaxel (CP), Atezolizumab, Bevacizumab-maly - Carboplatin and Paclitaxel (CP), Atezolizumab, Bevacizumab-onbe - Tecentriq/Avastin/Carboplatin/Taxol